Xiling Shen has a diverse work experience in various academic and research institutions. Currently, they serve as the CEO of xilis and the Chief Scientific Officer at the Terasaki Institute for Biomedical Innovation (TIBI), starting in November 2021. Prior to these roles, they worked as an Associate Professor at Duke University starting in July 2015. Xiling also held the position of Assistant Professor at Cornell University from an unknown start date until November 2021.
Xiling Shen attended Stanford University from 1997 to 2008. However, no specific degree or field of study is mentioned for this education period.
This person is not in any offices
Terasaki Institute for Biomedical Innovation (TIBI)
1 followers
The Terasaki Institute for Biomedical Innovation envisions a world where personalized medicine is available to all. Every person is unique with individual challenges to optimal health, from genetic predisposition to disease to socioeconomic barriers to care. We strive to address those challenges to bridge the gap between sickness and wellness. The Terasaki Institute for Biomedical Innovation aims to tackle the biggest problems in health. We are focused on solving problems in new ways, developing ‘personalized’ solutions, prototyping tangible solutions, and bringing our innovation to the real-world.